Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of Phenazopyridine Hydrochloride Tablets,
USP 200 mg as a short term analgesic treatment for the primary symptoms of pain or burning
when passing urine associated with uncomplicated urinary tract infections (uUTI)
Phase:
Phase 3
Details
Lead Sponsor:
Amneal Pharmaceuticals, LLC
Collaborators:
Biostudy Solutions, LLC Oxford Pharmaceutical Resources, Inc. Sristek Clinical Research